Back to User profile » Prof. Dr. Xuan Zhang

Papers published by Prof. Dr. Xuan Zhang:


Antitumor Activity of α-Linolenic Acid-Paclitaxel Conjugate Nanoparticles: In vitro and in vivo

Xu MQ, Hao YL, Wang JR, Li ZY, Li H, Feng ZH, Wang H, Wang JW, Zhang X

International Journal of Nanomedicine 2021, 16:7269-7281

Published Date: 27 October 2021

Enhancing Anti-Tumor Activity of Sorafenib Mesoporous Silica Nanomatrix in Metastatic Breast Tumor and Hepatocellular Carcinoma via the Co-Administration with Flufenamic Acid

Li ZY, Yin YF, Guo Y, Li H, Xu MQ, Liu M, Wang JR, Feng ZH, Duan XC, Zhang S, Zhang SQ, Wang GX, Liao A, Wang SM, Zhang X

International Journal of Nanomedicine 2020, 15:1809-1821

Published Date: 16 March 2020

Antitumor activity of the bioreductive prodrug 3-(2-nitrophenyl) propionic acid-paclitaxel nanoparticles (NPPA-PTX NPs) on MDA-MB-231 cells: in vitro and in vivo

Duan X, Yao X, Zhang S, Xu M, Hao Y, Li Z, Zheng X, Liu M, Li Z, Li H, Wang J, Feng Z, Zhang X

International Journal of Nanomedicine 2019, 14:195-204

Published Date: 24 December 2018

The theranostic efficiency of tumor-specific, pH-responsive, peptide-modified, liposome-containing paclitaxel and superparamagnetic iron oxide nanoparticles

Zheng XC, Ren W, Zhang S, Zhong T, Duan XC, Yin YF, Xu MQ, Hao YL, Li ZT, Li H, Liu M, Li ZY, Zhang X

International Journal of Nanomedicine 2018, 13:1495-1504

Published Date: 13 March 2018

The antitumor activity of tumor-homing peptide-modified thermosensitive liposomes containing doxorubicin on MCF-7/ADR: in vitro and in vivo

Wang C, Wang X, Zhong T, Zhao Y, Zhang WQ, Ren W, Huang D, Zhang S, Guo Y, Yao X, Tang YQ, Zhang X, Zhang Q

International Journal of Nanomedicine 2015, 10:2229-2248

Published Date: 19 March 2015

Antitumor effect of iRGD-modified liposomes containing conjugated linoleic acid–paclitaxel (CLA-PTX) on B16-F10 melanoma

Du R, Zhong T, Zhang WQ, Song P, Song WD, Zhao Y, Wang C, Tang YQ, Zhang X, Zhang Q

International Journal of Nanomedicine 2014, 9:3091-3105

Published Date: 24 June 2014

The antitumor activity of a doxorubicin loaded, iRGD-modified sterically-stabilized liposome on B16-F10 melanoma cells: in vitro and in vivo evaluation

Yu KF, Zhang WQ, Luo LM, Song P, Li D, Du R, Ren W, Huang D, Lu WL, Zhang X, Zhang Q

International Journal of Nanomedicine 2013, 8:2473-2485

Published Date: 15 July 2013

Antitumor activity of dichloroacetate on C6 glioma cell: in vitro and in vivo evaluation

Duan Y, Zhao X, Ren W, Wang X, Yu KF, Li D, Zhang X, Zhang Q

OncoTargets and Therapy 2013, 6:189-198

Published Date: 14 March 2013

Antitumor efficacy of a novel CLA-PTX microemulsion against brain tumors: in vitro and in vivo findings

Li D, Yang K, Li JS, Ke XY, Duan Y, Du R, Song P, Yu KF, Ren W, Huang D, Li XH, Hu X, Zhang X, Zhang Q

International Journal of Nanomedicine 2012, 7:6105-6114

Published Date: 17 December 2012

A silica-based pH-sensitive nanomatrix system improves the oral absorption and efficacy of incretin hormone glucagon-like peptide-1

Qu W, Li Y, Hovgaard L, Li S, Dai W, Wang J, Zhang X, Zhang Q

International Journal of Nanomedicine 2012, 7:4983-4994

Published Date: 14 September 2012